Press Releases
CluePoints Builds on Late Phase work in Japan and Launches Risk-Based Monitoring Roadshow in Tokyo
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has further expanded its Late Phase work in Japan by entering into two new partnerships with global top 20 pharmaceutical companies. ...
Press Releases
Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours
Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announced that it has begun a Phase 1b clinical program of its lead nanomedicine candidate CriPec®-docetaxel...
Press Releases
The future is now – Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery
Pharmapack Europe 2018 announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition taking place on 7–8 February at Paris Expo Porte de Versailles, Paris. The packed event programme includes...
Press Releases
Priorclave Wins Prestigious US Autoclave Contract
The largest and most recent export contract won by Priorclave is for shipment to the USA of nine research grade autoclaves which will be destined for the campus of California State University, Fullerton and will be used by faculty...
Press Releases
Clinerion expands the global coverage of its services in the Americas, adding 60 million patients in North America via partnership with Provisio Inc
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient...
Press Releases
Toyota Signs Licensing Agreement with Kazusa DNA Research Institute, Eurofins Genomics, and GeneBay for GRAS-Di DNA Analysis Technology
Toyota Motor Corporation (Toyota) announces that it has signed an agreement with Kazusa DNA Research Institute, Eurofins Genomics K.K., and GeneBay Inc. on October 30 to license Toyota's unique GRAS-Di(1) DNA analysis technology that can dramatically accelerate selective breeding....
Press Releases
First International Laboratory near Geneva, Switzerland to Support Clinical Trials opening announced by NeoGenomics
NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services in the United States, announced that it has opened its first international laboratory facility in Rolle, Switzerland, in the Canton of Vaud, just outside of Geneva as a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read